Codify — Article

Nova Scotia bill creates Health Ombudsman to investigate patient-safety failures

Establishes an independent Health Ombudsman with investigatory powers, mandatory responses from health authorities, public reporting and penalties — a new layer of oversight for patient safety.

The Brief

Bill 284 creates an independent officer of the House of Assembly called the Health Ombudsman and gives the office authority to receive complaints, launch investigations (including on its own initiative), summon witnesses and require documents from health authorities. The Ombudsman must be a qualified health professional with direct patient-care experience, serves a five-year term (renewable once), and may employ staff under the Civil Service Act.

Following investigations the Ombudsman must produce written reports to the complainant and the relevant health authority, recommend corrective actions, and monitor implementation. The bill allows the Ombudsman to publish investigation reports and health authority responses when the Ombudsman considers publication in the public interest or necessary for public safety, subject to redaction requirements.

The Act also creates offences for obstructing investigations and destroying evidence, and sets fines for individuals and corporations.

At a Glance

What It Does

Establishes the Health Ombudsman as an independent investigator of patient-safety incidents with power to receive complaints, compel information, and recommend corrective actions to health authorities. The Ombudsman may investigate on complaint or on the Ombudsman's own initiative, publish reports in the public interest, and monitor implementation of recommendations.

Who It Affects

Publicly funded health authorities and hospitals in Nova Scotia, patients and their families who seek reviews of care, healthcare workers who report systemic risks, and provincial government bodies responsible for funding and regulations. Civil service hires and health-authority staff will face new disclosure and cooperation obligations.

Why It Matters

The bill fills an accountability gap by creating a statutory, independent oversight office focused exclusively on patient-safety issues and systemic failures. For compliance officers and health executives it introduces mandatory reporting responses, monitoring requirements, and new reputational and regulatory risks tied to investigation findings and public disclosures.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The Act establishes a stand-alone Health Ombudsman as an officer of the House of Assembly, appointed by the Governor in Council with Assembly approval. The Ombudsman must be a qualified health professional with significant experience providing direct patient care and serves a five-year term renewable once.

The office may hire staff under the Civil Service Act and delegate powers in writing to those employees.

The Ombudsman accepts complaints from patients, former patients, caregivers (with consent), substitute decision-makers, estate representatives and, where appropriate, family members of deceased former patients. It also accepts information from healthcare workers and third parties about systemic patient-safety risks.

Complaints must relate to a defined list of patient-safety topics — for example death or serious injury from action or inaction, emergency response failures, neglect, unsafe staffing levels, serious medication errors, unreasonable delay or refusal of care, missed diagnosis, communication failures, repeated incidents and biased or inadequate internal investigations.On receipt of a complaint the Ombudsman must investigate unless the complaint is trivial, frivolous, vexatious, made in bad faith or the complainant lacks sufficient personal interest. The Ombudsman may also start investigations on its own initiative.

Investigations are conducted in private and the Ombudsman must inform the relevant health authority (and the complainant, where applicable) before starting. The Ombudsman has broad fact‑gathering powers: to hear witnesses, make inquiries, summon and examine persons under oath, and require documents and information.

Statutory protections limit use of statements given to the Ombudsman as evidence in other proceedings (with exceptions for perjury), and the Freedom of Information and Personal Health Information Acts do not prevent custodians from providing information when required by the Ombudsman.After an investigation the Ombudsman issues a written report to the health authority and complainant setting out findings, identified patient-safety or systemic issues, and recommended corrective actions. Health authorities must respond in writing within a regulatory time frame identifying whether recommendations are accepted or rejected, reasons for rejection, any alternative corrective action, responsible parties and implementation timelines; the Ombudsman will monitor implementation.

The Ombudsman may publish investigation reports and health authority responses when necessary for public safety or in the public interest, but must redact third‑party personal and health information. The Act also bars retaliation against complainants and providers who supply information, creates fines for obstruction or destruction of evidence, and authorizes regulations and appropriations to fund the office.

The Five Things You Need to Know

1

The Health Ombudsman is an officer of the House of Assembly appointed by the Governor in Council with Assembly approval and serves a five‑year term, renewable once.

2

The Ombudsman must be a qualified health professional with significant direct patient‑care experience and may hire staff under the Civil Service Act and delegate powers to them.

3

Investigations are private, but the Ombudsman can summon witnesses, require documents, examine under oath and share investigation material with other bodies when jurisdiction overlaps; statements to the Ombudsman are generally inadmissible in other proceedings (except perjury trials).

4

Health authorities must provide a written response to each recommended corrective action within a time set by regulation, including acceptance/rejection, reasons and implementation plans; the Ombudsman will monitor follow‑through and may publish responses.

5

The Act creates offences for obstructing investigations or destroying potential evidence and sets summary conviction fines up to $50,000 for individuals and $250,000 for corporations.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 3

Creation, appointment and qualifications of the Health Ombudsman

▾

This section establishes the Health Ombudsman as an officer of the House of Assembly, sets the appointment route (Governor in Council with Assembly approval) and fixes a five‑year term with one reappointment permitted. It requires the Ombudsman to be a qualified health professional with significant direct patient‑care experience and permits removal or suspension for cause. Practically, this links professional clinical credibility to the office and ties statutory tenure to executive appointment powers — factors that will shape perceptions of independence and the candidate pool.

Section 4

Staffing and delegation

▾

Section 4 authorizes the Ombudsman to employ staff under the Civil Service Act and to delegate powers in writing. That means the office will function within provincial human‑resources rules and can scale investigative capacity, but staffing choices, classification and pay will follow civil service processes. Delegation language allows investigations to be carried out by deputies and investigators while preserving legal accountability in the Ombudsman’s office.

Section 5

Scope of complaints and eligible complainants

▾

This section lists specific patient‑safety matters the Ombudsman may investigate — ranging from death or serious injury alleged to result from health‑authority action or inaction, to systemic staffing problems, medication errors, missed diagnoses and biased internal investigations. It also defines who may complain (patients, former patients, consented family or caregivers, substitute decision‑makers and estate representatives) and explicitly allows the Ombudsman to accept information from healthcare workers or others about systemic risks, widening avenues for whistleblowing.

5 more sections▾
Sections 6 and 7

Intake decisions and own‑initiative investigations; limits where litigation exists

▾

These sections require the Ombudsman to investigate complaints unless they are trivial, frivolous, not in good faith or the complainant lacks standing. They also permit the Ombudsman to open investigations on the Ombudsman’s own initiative. Both sections include limits: where matters are before the courts, the Ombudsman must narrow an investigation to avoid prejudicing legal proceedings. That creates a formalized interface between administrative fact‑finding and civil/criminal litigation.

Sections 8–11

Investigatory powers, privacy and evidentiary protections

▾

The Act requires the Ombudsman to notify relevant health authorities before investigations and conduct investigations in private. The Ombudsman may summon witnesses, require documents, examine under oath, and take information from anyone. Importantly, the Act provides privilege protections: statements made to the Ombudsman are generally inadmissible in other proceedings (except perjury trials), and persons compelled to produce information are insulated from prosecution under other Acts for compliance. It also clarifies that FOIPOP and PHIA do not bar custodians from disclosing information to the Ombudsman when required, while mandating redaction of third‑party personal information before reports are shared.

Section 12

Responses from health authorities and monitoring

▾

After investigations the Ombudsman issues written reports with recommended corrective actions; Section 12 obliges health authorities to respond in writing within a regulatory time frame detailing acceptance or rejection of each recommendation, reasons for rejection, planned actions, responsible parties and timelines. The Ombudsman must then monitor implementation according to regulations. This establishes a two‑step accountability loop—recommendation then mandatory response and oversight of follow‑through—without granting the Ombudsman direct enforcement powers.

Section 13

Annual and special reporting to the House of Assembly; public availability

▾

Section 13 requires an annual report to the House of Assembly with detailed operational metrics (complaints received, investigations conducted, types of incidents, recurring concerns and progress on corrective actions). It also allows special reports for urgent systemic concerns or failure to implement recommendations. The Ombudsman must make these reports public, but must not include personal health or personal information, reinforcing the office’s dual accountability to the legislature and the public.

Sections 14–16 and 17

Protections, penalties, regulations and funding

▾

The Act prohibits retaliation against complainants or witnesses and creates summary conviction offences and fines for obstruction or destruction of evidence. The Governor in Council can make regulations on redaction exceptions, timing for health‑authority responses, monitoring regimes and other implementation matters. Finally, Section 17 specifies that the office requires legislative appropriation, making implementation contingent on budget allocation decisions.

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Patients and former patients — gain an independent avenue to investigate serious care failures and systemic safety issues when internal processes are perceived as inadequate.
  • Families and estate representatives of deceased patients — receive a statutory mechanism to investigate deaths allegedly caused by health‑authority action or inaction.
  • Healthcare workers and whistleblowers — benefit from a formal reporting channel for systemic patient‑safety risks and statutory anti‑retaliation protections that reduce fear of reprisal.
  • Provincial policymakers and the House of Assembly — receive consolidated, comparable data and special reports to inform policy decisions and legislative oversight of health authorities.

Who Bears the Cost

  • Health authorities and hospitals — must allocate staff time and administrative resources to responding to investigations, prepare redacted information, implement corrective actions and produce written responses within regulatory timelines.
  • Healthcare providers and managers named in investigations — face investigative scrutiny, potential reputational harm and the operational burden of cooperating with subpoenas and preservation notices.
  • Provincial government (Treasury) — must appropriate funds to establish and staff the Ombudsman’s office and cover ongoing investigative costs, monitoring and public reporting.
  • Legal teams and compliance departments at health authorities — will incur additional legal review costs to manage interfaces with litigation, privacy law redactions and to respond to summonses while protecting legal interests.

Key Issues

The Core Tension

The central dilemma is between creating a powerful, independent investigatory body that promotes transparency and protecting the integrity of legal processes, patient privacy and health‑authority operational autonomy: the bill expands oversight and encourages candid reporting, but its admissibility protections, reliance on recommendations (not enforcement) and delegation of redaction and timing details to regulation mean stronger oversight may come at the cost of legal complexity, operational burden and uncertain effectiveness.

The Act gives the Ombudsman broad investigatory tools but stops short of coercive enforcement: the office can recommend actions and monitor implementation, and can publish reports to shame non‑compliance, but it cannot compel corrective measures beyond statutory reporting and public disclosure. That design relies on reputational pressure and legislative oversight rather than administrative sanctions, which could limit effectiveness if health authorities decline substantive changes or if the public interest test for publication is applied narrowly.

The evidentiary rules and privacy carve‑outs create operational tensions. Statements and documents gathered by the Ombudsman are generally inadmissible in other proceedings, which may encourage candid internal reporting but could frustrate civil plaintiffs seeking material for malpractice suits.

Conversely, requiring custodians to disclose PHIA/FOIPOP‑protected information to the Ombudsman raises questions about record redaction practices, timelines and appeal rights. The bill instructs the Ombudsman to redact third‑party personal information before publishing, but it leaves the detailed redaction rules and timing to regulation, creating implementation friction.

Finally, the Ombudsman’s appointment and removal mechanics (Governor in Council with Assembly approval; removal for cause) and the statutory requirement that the Ombudsman be a health professional create trade‑offs between clinical credibility and perceived independence. Funding depends on legislative appropriation, which means the office’s investigative capacity could be constrained in practice.

Those structural choices will shape how aggressively the office can investigate systemic problems and follow through on monitoring obligations.

There's more to this law than the bill.

Codify Laws traces every connection across the legislative lifecycle.

Bill↓Regulations↓Statute↓Proclamation↓In-Force Date
Try Codify Laws →